EAM
LLY icon

Exome Asset Management’s Eli Lilly LLY Stock Holding History

Exome Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Sell
5,492
-1,520
-22% -$1.55M 4.06% 6
2026
Q1 		$6.45M Sell
7,012
-840
-11% -$852K 3.34% 8
2025
Q4 		$8.44M Hold
7,852
– – 4.03% 5
2025
Q3 		$5.99M Buy
7,852
+3,179
+68% +$2.37M 3.63% 6
2025
Q2 		$3.64M Hold
4,673
– – 2.71% 11
2025
Q1 		$3.86M Sell
4,673
-3,574
-43% -$2.97M 3.43% 8
2024
Q4 		$6.37M Sell
8,247
-2,200
-21% -$1.82M 4.78% 2
2024
Q3 		$9.26M Buy
10,447
+747
+8% +$672K 6.26% 1
2024
Q2 		$8.78M Hold
9,700
– – 7.82% 1
2024
Q1 		$7.55M Hold
9,700
– – 6.46% 1
2023
Q4 		$5.65M Buy
+9,700
New +$5.66M 5.59% 2

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exome Asset Management's LLY Position: Q2 2026 in Review

Exome Asset Management reduced its Eli Lilly (LLY) stake by 22% in Q2 2026, selling an estimated $1.55M and leaving 5,492 shares worth $6.59M. The position accounts for 4.06% of the portfolio, ranked #6.

Exome Asset Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.26M in Q3 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Exome Asset Management held 5,492 shares of Eli Lilly worth $6.59M as of Q2 2026.
  • Exome Asset Management sold 1,520 Eli Lilly shares in Q2 2026, an estimated $1.55M.
  • Eli Lilly made up 4.06% of Exome Asset Management's portfolio in Q2 2026, its #6 holding.
  • Exome Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Exome Asset Management's Eli Lilly position peaked at $9.26M in Q3 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.